基于肺超声LUS评分评估不同水平PEEP通气对老年患者腹腔镜日间手术后肺不张的影响

注册号:

Registration number:

ChiCTR2500098563 

最近更新日期:

Date of Last Refreshed on:

2025-03-11 08:52:46 

注册时间:

Date of Registration:

2025-03-11 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

基于肺超声LUS评分评估不同水平PEEP通气对老年患者腹腔镜日间手术后肺不张的影响

Public title:

To evaluate the effect of different levels of PEEP ventilation on atelectasis in elderly patients after laparoscopic ambulatory surgery based on LUS score

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于肺超声LUS评分评估不同水平PEEP通气对老年患者腹腔镜日间手术后肺不张的影响

Scientific title:

To evaluate the effect of different levels of PEEP ventilation on atelectasis in elderly patients after laparoscopic ambulatory surgery based on LUS score

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王凯 

研究负责人:

王凯 

Applicant:

Wang Kai 

Study leader:

Wang Kai 

申请注册联系人电话:

Applicant telephone:

+86 13817831860

研究负责人电话:

Study leader's
telephone:

+86 21 67073174

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

victorwaaa@163.com

研究负责人电子邮件:

Study leader's E-mail:

victorwaaa@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市嘉定区城北路1号

研究负责人通讯地址:

上海市嘉定区城北路1号

Applicant address:

NO.1, Chengbei Road, Jiading District, Shanghai City, China

Study leader's address:

NO.1, Chengbei Road, Jiading District, Shanghai City, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海市嘉定区中心医院

Applicant's institution:

Shanghai Jiading District Central Hospital

研究负责人所在单位:

上海市嘉定区中心医院

Affiliation of the Leader:

Shanghai Jiading Central Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2024K15

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市嘉定区中心医院医学研究伦理委员会

Name of the ethic committee:

Medical Research Ethics Committee of Jiading District District Central Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2024-08-08 00:00:00

伦理委员会联系人:

刘顾晟

Contact Name of the ethic committee:

Liu Gusheng

伦理委员会联系地址:

上海市嘉定区城北路1号

Contact Address of the ethic committee:

NO.1, Chengbei Road, Jiading District, Shanghai City, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 67073430

伦理委员会联系人邮箱:

Contact email of the ethic committee:

1747512381@qq.com

研究实施负责(组长)单位:

上海市嘉定区中心医院

Primary sponsor:

Shanghai Jiading Central Hospital

研究实施负责(组长)单位地址:

上海市嘉定区城北路1号

Primary sponsor's address:

NO.1, Chengbei Road, Jiading District, Shanghai City, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市嘉定区中心医院

具体地址:

上海市嘉定区城北路1号

Institution
hospital:

Shanghai Jiading Central Hospital

Address:

NO.1, Chengbei Road, Jiading District, Shanghai City, China

经费或物资来源:

嘉定区卫健委课题

Source(s) of funding:

Project of Jiading District Health Committee

研究疾病:

肺不张  

Target disease:

pulmonary atelectasis

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

通过本研究,应用肺超声LUS评分评估并指导日间手术患者全身麻醉期间机械通气PEEP水平的设置;寻找适合日间手术应用的肺复张方法;为改善老年患者日间手术管理提供更多的临床依据。  

Objectives of Study:

In this study, the LUS score of lung ultrasound was used to evaluate and guide the setting of mechanical ventilation PEEP during general anesthesia in patients undergoing day surgery. To find a lung reexpansion method suitable for day surgery; To provide more clinical basis for improving the management of day operation in elderly patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.术后疼痛评分4分及以上者; 2.合并有呼吸系统疾病,如COPD、慢支、哮喘、肺大泡、术前上呼吸道感染等、心肺功能不全及其它重大疾病患者; 3.急诊手术; 4.身高<150cm或体重指数>30 kg/m^2; 5.术中血流动力学不稳定者; 6.术前贫血(血红蛋白<100 g/L)的患者; 7.既往有胸部手术史;

Exclusion criteria:

1. Postoperative VAS pain score of 4 or more; 2. Patients with respiratory diseases, such as COPD, chronic branch, asthma, pulmonary bulla, preoperative upper respiratory tract infection, cardiopulmonary insufficiency and other serious disease; 3. Emergency surgery; 4. Height <150cm or body mass index >30 kg/m^2; 5. Patients with intraoperative hemodynamic instability; 6. Patients with preoperative anemia (hemoglobin <100 g/L); 7. Have a history of chest surgery.

研究实施时间:

Study execute time:

From 2023-10-01 00:00:00 To 2026-09-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-08-27 00:00:00 To 2025-11-30 00:00:00

干预措施:

Interventions:

组别:

Ⅰ组

样本量:

40

Group:

Ⅰgroup

Sample size:

干预措施:

呼气末正压通气PEEP=5cm H20

干预措施代码:

Intervention:

Positive end-expiratory pressure ventilation PEEP=5cm H20

Intervention code:

组别:

Ⅱ组

样本量:

40

Group:

Ⅱ group

Sample size:

干预措施:

呼气末正压通气PEEP=8cm H20

干预措施代码:

Intervention:

Positive end-expiratory pressure ventilation PEEP=8cm H20

Intervention code:

组别:

Ⅲ组

样本量:

40

Group:

Ⅲ group

Sample size:

干预措施:

呼气末正压通气PEEP=10cm H20

干预措施代码:

Intervention:

Positive end-expiratory pressure ventilation PEEP=10cm H20

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市嘉定区中心医院 

单位级别:

二级甲等 

Institution
hospital:

Shanghai Jiading Central Hospital

Level of the institution:

Secondary A

测量指标:

Outcomes:

指标中文名:

肺超声评分

指标类型:

主要指标

Outcome:

Lung ultrasound score

Type:

Primary indicator

测量时间点:

术前(T1),全麻拔管后30分钟(T2),术后20-30小时(T3)

测量方法:

采用十二分区法检查,每侧由胸骨旁线、腋前线、腋后线将胸廓分成前、侧、后三个区,再以前胸第四肋间隙水平(约两乳头连线水平)分为上、下两部分,即双肺按体表标志共分为十二区。每个时间点十二区仔细、广泛扫查。将每个区域超声下观察到的最严重的影像录制下来并保存,每个区域至少留取一段影像,若一段影像不能完全反映该区情况则可以加录影像或者截取图片保存。

Measure time point of outcome:

Preoperative (T1), 30 minutes after extubation under general anesthesia (T2), and 20-30 hours after surgery (T3)

Measure method:

Twelve area method was used for examination. The thorax was divided into anterior, lateral and posterior areas by the parasternal line, anterior axillary line and posterior axillary line on each side, and then divided into upper and lower parts at the level of the fourth costal space in the anterior chest (about the level of the line between the two nipples), that is, the lungs were divided into twelve areas according to the body surface markers. Careful, extensive sweep of 12 zones at each time

指标中文名:

呼吸力学指标:气道峰压、气道平台压

指标类型:

次要指标

Outcome:

Respiratory mechanical index: peak airway pressure, plateau airway pressure

Type:

Secondary indicator

测量时间点:

术中

测量方法:

呼吸机监测

Measure time point of outcome:

During operation

Measure method:

Ventilator monitoring

指标中文名:

血流动力学指标:心率、平均动脉压

指标类型:

次要指标

Outcome:

Hemodynamic index: heart rate, mean arterial pressure

Type:

Secondary indicator

测量时间点:

诱导前、插管后、切皮、术毕、拔管前及拔管后

测量方法:

有创动脉测压

Measure time point of outcome:

Before general anesthesia induction, after intubation, skin resection, after surgery, before extubat

Measure method:

Invasive arterial pressure measurement

指标中文名:

血氧饱和度

指标类型:

次要指标

Outcome:

Blood oxygen saturation

Type:

Secondary indicator

测量时间点:

术前(T1),全麻拔管后30分钟(T2),术后20-30小时(T3)

测量方法:

指脉氧监测

Measure time point of outcome:

Preoperative (T1), 30 minutes after extubation under general anesthesia (T2), and 20-30 hours after surgery (T3)

Measure method:

Pulse oxygen monitoring

指标中文名:

疼痛数字评分(NRS)

指标类型:

次要指标

Outcome:

Numerical Pain Score (NRS)

Type:

Secondary indicator

测量时间点:

全麻拔管后30分钟(T2),术后20-30小时(T3)

测量方法:

问诊

Measure time point of outcome:

General anesthesia 30 minutes after extubation (T2), 20-30 hours after surgery (T3)

Measure method:

interrogation

指标中文名:

免疫学指标:白介素IL-1β、IL-16、IL-6、肿瘤坏死因子TNF-α

指标类型:

次要指标

Outcome:

Immunological indicators: interleukin IL-1 β IL-16IL-6 Tumor necrosis factor TNF - α

Type:

Secondary indicator

测量时间点:

术前(T1),术后20-30小时(T3)

测量方法:

血标本化验

Measure time point of outcome:

Before surgery(T1), 20-30 hours after surgery (T3)

Measure method:

Blood specimen assay

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 65 years
最大 Max age 85 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

单盲,对评估者设盲

Blinding:

Single blind study with blinded-evaluators

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2027.01.01,https://pan.baidu.com/s/1KB9JEs5iHLiwLWBmzK0HDg

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

2027.01.01,https://pan.baidu.com/s/1KB9JEs5iHLiwLWBmzK0HDg

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2025-03-11 08:52:26